Form 4 for EDIT Editas Medicine, Inc.
Accepted 2023-07-25 00:00:00 ET · period of report 2023-07-24 · accession 0001415889-23-011455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-25 | 2023-07-24 | EDIT | Burkly Linda | EVP, CSO | A - Grant | $0.00 | +45.2K | 45.2K | New | $0 |
| D | 2023-07-25 | 2023-07-24 | EDIT | Burkly Linda | EVP, CSO | A - Grant | $0.00 | +135.5K | 135.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-24 | A | A | 45,167 | $0.00 | 45,167 | D | — | — | (F1) The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 24, 2024 continuing through July 24, 2027. |
| 2 | Derivative | Stock Option (right to buy) | 2023-07-24 | A | A | 135,500 | $0.00 | 135,500 | D | $8.66 · — to 2033-07-23 | 135,500 Common Stock | (F2) This option was granted on July 24, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on July 24, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 24, 2027. |